Immutep Ltd Adr Stock Net Income
| IMMP Stock | USD 1.91 0.06 3.24% |
Immutep Ltd ADR fundamentals help investors to digest information that contributes to Immutep's financial success or failures. It also enables traders to predict the movement of Immutep Stock. The fundamental analysis module provides a way to measure Immutep's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immutep stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -38.4 M | -36.5 M | |
| Net Loss | -38.4 M | -40.4 M | |
| Net Loss | -35.9 M | -37.7 M | |
| Net Loss | (0.05) | (0.06) | |
| Net Income Per E B T | 1.15 | 1.09 |
Immutep | Net Income |
Immutep Ltd ADR Company Net Income Analysis
Immutep's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Immutep Net Income | (42.72 M) |
Most of Immutep's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Immutep Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Immutep is extremely important. It helps to project a fair market value of Immutep Stock properly, considering its historical fundamentals such as Net Income. Since Immutep's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immutep's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immutep's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Immutep Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Immutep Ltd ADR reported net income of (42.72 Million). This is 112.52% lower than that of the Biotechnology sector and 160.98% lower than that of the Health Care industry. The net income for all United States stocks is 107.48% higher than that of the company.
Immutep Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immutep's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics of similar companies.Immutep is currently under evaluation in net income category among its peers.
Immutep Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immutep from analyzing Immutep's financial statements. These drivers represent accounts that assess Immutep's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immutep's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 61.8M | 310.2M | 229.8M | 257.6M | 296.2M | 414.3M | |
| Enterprise Value | 44.5M | 252.9M | 151.6M | 135.4M | 155.7M | 147.9M |
Immutep Institutional Holders
Institutional Holdings refers to the ownership stake in Immutep that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Immutep's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immutep's value.| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 29.6 K | Rhumbline Advisers | 2024-12-31 | 28.7 K | Ubs Group Ag | 2024-12-31 | 23 K | Geode Capital Management, Llc | 2024-12-31 | 18.7 K | Old Mission Capital Llc | 2024-12-31 | 16.8 K | Millennium Management Llc | 2024-12-31 | 16.4 K | Simplex Trading, Llc | 2024-12-31 | 10.3 K | Tower Research Capital Llc | 2024-12-31 | 5.6 K | Royal Bank Of Canada | 2024-12-31 | 4.9 K | Blackrock Inc | 2024-12-31 | 740.4 K | Meridian Wealth Management, Llc | 2024-12-31 | 394.1 K |
Immutep Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.2 | ||||
| Operating Margin | (8.39) % | ||||
| Current Valuation | 162.74 M | ||||
| Shares Outstanding | 145.56 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 2.05 % | ||||
| Number Of Shares Shorted | 5.09 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 2.41 X | ||||
| Price To Sales | 55.05 X | ||||
| Revenue | 3.84 M | ||||
| Gross Profit | (41.56 M) | ||||
| EBITDA | (44.54 M) | ||||
| Net Income | (42.72 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.12 X | ||||
| Cash Flow From Operations | (34.82 M) | ||||
| Short Ratio | 69.58 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 9.5 | ||||
| Beta | 1.98 | ||||
| Market Capitalization | 268.56 M | ||||
| Total Asset | 201.58 M | ||||
| Retained Earnings | (382.65 M) | ||||
| Working Capital | 180.86 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
| Net Asset | 201.58 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.